Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Cathy Bradley

Concepts (501)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Employment
41
2025
184
10.300
Why?
Neoplasms
72
2025
2913
9.410
Why?
Medicaid
37
2023
467
7.560
Why?
Breast Neoplasms
49
2024
2393
5.120
Why?
Cancer Survivors
17
2025
338
5.080
Why?
Insurance Coverage
22
2024
244
4.210
Why?
Medicare
36
2025
904
3.860
Why?
Insurance, Health
20
2024
311
3.510
Why?
Cost of Illness
14
2024
324
3.150
Why?
SEER Program
22
2024
230
3.060
Why?
Poverty
13
2022
529
2.770
Why?
Medically Uninsured
12
2020
132
2.420
Why?
Healthcare Disparities
14
2020
736
2.310
Why?
Colorectal Neoplasms
16
2025
868
2.300
Why?
United States
97
2025
16123
2.240
Why?
Uterine Cervical Neoplasms
7
2020
268
2.210
Why?
Health Services Accessibility
18
2024
1101
2.180
Why?
Survivors
17
2022
523
2.060
Why?
Early Detection of Cancer
10
2024
486
2.030
Why?
Medical Oncology
6
2024
340
1.940
Why?
Registries
33
2026
2410
1.820
Why?
Health Benefit Plans, Employee
5
2022
25
1.800
Why?
Health Care Costs
14
2024
425
1.740
Why?
Antineoplastic Agents
9
2025
2219
1.740
Why?
Humans
205
2026
145763
1.710
Why?
Carcinoma, Non-Small-Cell Lung
6
2025
1191
1.700
Why?
Survivorship
4
2022
57
1.550
Why?
Drug Costs
4
2025
117
1.490
Why?
Health Care Reform
4
2021
109
1.420
Why?
Lung Neoplasms
11
2025
2667
1.400
Why?
Caregivers
6
2023
1074
1.380
Why?
Aged
77
2025
26215
1.260
Why?
Colonic Neoplasms
5
2016
258
1.240
Why?
Female
130
2026
79035
1.230
Why?
Policy
4
2024
149
1.170
Why?
Prostatic Neoplasms
11
2022
981
1.160
Why?
Research
6
2022
431
1.160
Why?
Middle Aged
79
2026
36302
1.150
Why?
Mental Health
4
2023
796
1.140
Why?
Socioeconomic Factors
20
2022
1327
1.140
Why?
Michigan
24
2015
134
1.130
Why?
Prescription Drugs
2
2023
111
1.080
Why?
Income
8
2024
203
1.070
Why?
Efficiency
7
2016
103
1.040
Why?
Neoplasm Staging
17
2022
1474
1.030
Why?
Male
99
2026
73003
1.020
Why?
Health Status
10
2013
835
1.000
Why?
Medical Record Linkage
2
2021
69
0.960
Why?
Aged, 80 and over
37
2025
8346
0.960
Why?
Health Status Disparities
2
2023
321
0.960
Why?
Papanicolaou Test
2
2017
35
0.950
Why?
Adult
69
2026
40872
0.940
Why?
Primary Health Care
6
2023
1737
0.880
Why?
Motivation
2
2020
602
0.860
Why?
Safety-net Providers
3
2017
130
0.840
Why?
Occupational Medicine
1
2024
14
0.840
Why?
Cancer Care Facilities
4
2024
48
0.830
Why?
Medicare Part C
1
2025
36
0.820
Why?
Patient Acceptance of Health Care
4
2018
883
0.800
Why?
Eligibility Determination
5
2018
72
0.790
Why?
Comorbidity
12
2019
1662
0.770
Why?
Communication
3
2024
977
0.770
Why?
Quality of Life
8
2023
3210
0.760
Why?
Health Expenditures
8
2023
194
0.750
Why?
Colonoscopy
4
2019
264
0.750
Why?
Return to Work
4
2022
21
0.740
Why?
Absenteeism
4
2013
52
0.720
Why?
Virginia
7
2018
57
0.700
Why?
Mass Screening
10
2022
1361
0.700
Why?
Occupational Health
1
2024
213
0.680
Why?
Focus Groups
1
2024
572
0.680
Why?
Workplace
4
2021
272
0.660
Why?
Medication Adherence
2
2023
540
0.660
Why?
Young Adult
27
2026
14251
0.660
Why?
Mammography
5
2024
166
0.640
Why?
Cost Sharing
1
2020
20
0.610
Why?
Models, Economic
2
2011
62
0.610
Why?
Health Equity
1
2022
133
0.600
Why?
Information Dissemination
1
2022
224
0.600
Why?
Public Health
1
2024
574
0.580
Why?
Chemotherapy, Adjuvant
7
2023
427
0.570
Why?
Perioperative Care
1
2021
231
0.570
Why?
Preventive Health Services
5
2023
153
0.570
Why?
Health Planning Guidelines
1
2018
24
0.570
Why?
Retirement
5
2022
35
0.560
Why?
Health Facilities
1
2019
85
0.550
Why?
Spouses
3
2017
108
0.540
Why?
Cost-Benefit Analysis
9
2024
644
0.530
Why?
Quality Indicators, Health Care
1
2020
336
0.530
Why?
Diagnostic Imaging
1
2020
337
0.530
Why?
Survival Analysis
10
2019
1378
0.530
Why?
Reimbursement, Incentive
1
2017
42
0.510
Why?
Healthy People Programs
1
2016
7
0.480
Why?
Occupational Health Services
2
2016
37
0.480
Why?
Bevacizumab
1
2017
168
0.470
Why?
Logistic Models
13
2023
2139
0.470
Why?
Job Satisfaction
3
2013
238
0.460
Why?
Job Description
2
2013
10
0.460
Why?
Massachusetts
4
2021
180
0.460
Why?
Triple Negative Breast Neoplasms
3
2023
218
0.460
Why?
Outpatients
1
2019
447
0.450
Why?
Hematopoietic Stem Cell Transplantation
1
2021
699
0.440
Why?
Length of Stay
6
2012
1350
0.440
Why?
Chronic Pain
1
2019
292
0.430
Why?
State Government
3
2014
46
0.430
Why?
Rectal Neoplasms
1
2016
159
0.420
Why?
Fee-for-Service Plans
4
2023
99
0.420
Why?
Vaginal Smears
1
2014
54
0.420
Why?
Nursing Homes
4
2013
174
0.420
Why?
Longitudinal Studies
11
2022
2967
0.410
Why?
Health Services Research
4
2010
391
0.410
Why?
Mouth Neoplasms
3
2019
90
0.400
Why?
Emergency Treatment
1
2015
123
0.400
Why?
General Practice
1
2014
32
0.400
Why?
Databases, Factual
8
2026
1491
0.400
Why?
Risk Factors
16
2026
10917
0.390
Why?
Sick Leave
2
2019
16
0.390
Why?
Delivery of Health Care
5
2024
947
0.390
Why?
Cross-Sectional Studies
13
2023
5922
0.380
Why?
Sickness Impact Profile
1
2013
62
0.370
Why?
Behavioral Risk Factor Surveillance System
4
2017
57
0.370
Why?
Health Personnel
3
2022
757
0.370
Why?
Diabetes Mellitus, Type 2
4
2015
2602
0.370
Why?
Insurance Claim Review
2
2010
83
0.360
Why?
Marital Status
3
2007
46
0.360
Why?
Value of Life
2
2008
19
0.360
Why?
Homes for the Aged
2
2013
33
0.360
Why?
Work
3
2010
23
0.350
Why?
Cohort Studies
10
2025
6032
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2023
1969
0.350
Why?
Age Factors
11
2022
3346
0.340
Why?
Colorado
5
2026
4556
0.340
Why?
Survival Rate
7
2020
2094
0.340
Why?
Neoplasm Metastasis
3
2020
688
0.330
Why?
Health Services
1
2012
113
0.330
Why?
Periodicals as Topic
2
2023
209
0.330
Why?
Patient Protection and Affordable Care Act
3
2024
103
0.320
Why?
Hypoglycemia
1
2015
480
0.320
Why?
Quality Improvement
2
2018
1296
0.320
Why?
Social Class
4
2022
264
0.320
Why?
Physician Self-Referral
1
2010
1
0.320
Why?
Surgical Procedures, Operative
2
2012
271
0.310
Why?
Intestinal Perforation
3
2016
46
0.310
Why?
Models, Econometric
6
2017
35
0.300
Why?
Financing, Personal
2
2019
27
0.300
Why?
Carcinoma, Squamous Cell
3
2019
641
0.300
Why?
Biomedical Research
2
2020
719
0.300
Why?
Data Collection
3
2014
643
0.300
Why?
Waiting Lists
1
2011
266
0.300
Why?
Radiation Oncology
1
2010
82
0.290
Why?
Astrocytoma
1
2010
130
0.290
Why?
Costs and Cost Analysis
2
2022
221
0.290
Why?
Physicians
1
2018
956
0.290
Why?
Recovery of Function
1
2013
716
0.290
Why?
Gastrointestinal Hemorrhage
3
2016
138
0.290
Why?
Surveys and Questionnaires
12
2018
6085
0.280
Why?
Dentists
1
2008
21
0.280
Why?
Persuasive Communication
1
2008
14
0.280
Why?
Administration, Oral
2
2023
867
0.280
Why?
Dental Care
1
2008
25
0.280
Why?
Life Expectancy
1
2008
73
0.270
Why?
Oropharyngeal Neoplasms
2
2018
56
0.270
Why?
Multivariate Analysis
9
2019
1547
0.270
Why?
Propensity Score
1
2010
377
0.270
Why?
Odds Ratio
9
2014
1083
0.260
Why?
Stroke
3
2026
1271
0.250
Why?
HIV Infections
2
2022
3195
0.250
Why?
Pneumonectomy
1
2008
167
0.250
Why?
Patient Education as Topic
1
2011
777
0.240
Why?
Likelihood Functions
5
2021
138
0.240
Why?
Confidence Intervals
4
2013
330
0.240
Why?
Women, Working
2
2002
11
0.230
Why?
Quality-Adjusted Life Years
4
2017
125
0.230
Why?
Depression
4
2021
1557
0.230
Why?
Time Factors
11
2013
7133
0.230
Why?
Online Systems
1
2005
20
0.230
Why?
Sex Factors
7
2026
2110
0.230
Why?
Forecasting
6
2020
390
0.220
Why?
Colonic Diseases
2
2016
37
0.220
Why?
Disability Evaluation
1
2007
311
0.220
Why?
Cost Savings
2
2018
86
0.220
Why?
Adolescent
15
2026
22573
0.220
Why?
Education, Medical, Graduate
1
2010
562
0.220
Why?
Treatment Outcome
12
2019
11793
0.220
Why?
Myocardial Infarction
3
2023
1211
0.210
Why?
Cross Infection
2
2017
260
0.210
Why?
Health Services Needs and Demand
3
2017
280
0.210
Why?
Anxiety
3
2021
1122
0.210
Why?
Leukemia, Myeloid, Acute
1
2011
688
0.200
Why?
Methicillin-Resistant Staphylococcus aureus
2
2017
251
0.200
Why?
Models, Statistical
4
2017
672
0.200
Why?
Referral and Consultation
1
2010
868
0.200
Why?
Probability
5
2023
308
0.200
Why?
Needs Assessment
2
2024
403
0.200
Why?
Head and Neck Neoplasms
2
2019
561
0.190
Why?
Hospitals, Public
1
2023
30
0.190
Why?
Physician-Patient Relations
1
2008
588
0.190
Why?
Time-to-Treatment
1
2025
251
0.190
Why?
Community-Based Participatory Research
1
2024
168
0.190
Why?
Substance-Related Disorders
3
1997
1102
0.190
Why?
Economics, Medical
1
2022
6
0.190
Why?
Staphylococcal Infections
2
2017
393
0.190
Why?
Hormones
1
2023
135
0.180
Why?
Carcinoma
2
2017
227
0.180
Why?
Age Distribution
4
2020
404
0.180
Why?
Salaries and Fringe Benefits
1
2002
58
0.180
Why?
Migraine Disorders
1
2024
114
0.180
Why?
Colonic Polyps
2
2014
88
0.180
Why?
Health Behavior
2
2019
791
0.180
Why?
Bisexuality
1
2022
39
0.180
Why?
Food Supply
1
2022
89
0.180
Why?
Smoking
2
2019
1477
0.180
Why?
Hospital Charges
3
2003
46
0.180
Why?
Risk Assessment
6
2022
3752
0.180
Why?
Proportional Hazards Models
5
2019
1330
0.180
Why?
Ambulatory Care Facilities
1
2024
269
0.170
Why?
Incidence
5
2022
2933
0.170
Why?
Insulin, Isophane
1
2001
22
0.170
Why?
Evidence-Based Medicine
2
2016
740
0.170
Why?
Hypoglycemic Agents
3
2018
1399
0.170
Why?
Analgesics, Opioid
2
2021
1154
0.160
Why?
Intensive Care Units
2
2017
924
0.160
Why?
Neoplasm Recurrence, Local
3
2021
1150
0.160
Why?
Brain Neoplasms
1
2010
1331
0.160
Why?
Kentucky
1
2020
43
0.160
Why?
Internet
1
2005
693
0.160
Why?
Exercise
3
2023
2205
0.160
Why?
Retrospective Studies
13
2024
17325
0.160
Why?
Homosexuality, Male
1
2022
231
0.160
Why?
Decision Making
2
2005
982
0.160
Why?
Delayed Diagnosis
1
2020
100
0.150
Why?
Sample Size
1
2000
121
0.150
Why?
Population Surveillance
2
2022
484
0.150
Why?
California
2
2018
473
0.150
Why?
Regression Analysis
5
2021
1001
0.150
Why?
Carrier State
2
2017
78
0.150
Why?
Hospitalization
5
2016
2460
0.150
Why?
Benzodiazepines
1
2021
168
0.150
Why?
Stress, Psychological
2
2021
1149
0.150
Why?
Language Development Disorders
1
2019
41
0.140
Why?
Ownership
2
2010
115
0.140
Why?
Infection Control
2
2017
173
0.140
Why?
Feasibility Studies
1
2023
1115
0.140
Why?
Anthracyclines
3
2023
49
0.140
Why?
Los Angeles
2
2015
73
0.140
Why?
Patient Selection
3
2010
739
0.140
Why?
National Cancer Institute (U.S.)
3
2023
54
0.140
Why?
Child
7
2024
22739
0.140
Why?
Diabetes Mellitus
3
2018
1101
0.140
Why?
Patient Care Team
1
2024
697
0.140
Why?
Exercise Therapy
1
2023
475
0.140
Why?
Taxoids
3
2023
114
0.140
Why?
Activities of Daily Living
2
2010
444
0.140
Why?
Cetuximab
1
2018
111
0.140
Why?
Radiotherapy, Adjuvant
1
2019
222
0.140
Why?
Carboplatin
1
2018
164
0.140
Why?
Hyperlipidemias
1
2019
120
0.140
Why?
Ireland
2
2016
32
0.130
Why?
Cancer Pain
1
2018
39
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2019
444
0.130
Why?
Research Design
4
2007
1139
0.130
Why?
Infant, Newborn
4
2020
6464
0.130
Why?
Unemployment
2
2009
43
0.130
Why?
Managed Care Programs
1
2018
140
0.130
Why?
Hypertension
2
2024
1276
0.130
Why?
Financing, Government
1
2017
53
0.130
Why?
Accidental Falls
1
2020
230
0.130
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2017
61
0.130
Why?
Public Health Practice
1
2017
63
0.130
Why?
Combined Modality Therapy
4
2019
1270
0.130
Why?
Patient Rights
2
2019
11
0.130
Why?
Attitude to Health
3
2019
430
0.120
Why?
Hospital Costs
2
2011
125
0.120
Why?
Inpatients
2
2012
553
0.120
Why?
Psychiatric Department, Hospital
1
1996
12
0.120
Why?
Patient Discharge
1
2023
995
0.120
Why?
Cisplatin
1
2018
345
0.120
Why?
Sex Distribution
3
2020
388
0.120
Why?
Child Behavior
1
1998
236
0.120
Why?
Drug Therapy
1
2017
84
0.120
Why?
Heart Failure
2
2023
2326
0.120
Why?
Self Efficacy
1
2019
413
0.120
Why?
Language
1
2019
324
0.120
Why?
Lymph Nodes
1
2019
509
0.120
Why?
Ambulatory Surgical Procedures
1
2016
79
0.110
Why?
Smoking Cessation
1
2019
441
0.110
Why?
Neonatal Abstinence Syndrome
1
1996
27
0.110
Why?
Clinical Competence
2
2014
1247
0.110
Why?
Colorectal Surgery
1
2015
30
0.110
Why?
Patient Admission
1
1997
220
0.110
Why?
Minority Groups
1
2017
285
0.110
Why?
Residence Characteristics
2
2008
375
0.110
Why?
Metformin
1
2018
329
0.110
Why?
Child, Preschool
4
2020
11868
0.110
Why?
Case-Control Studies
4
2024
3634
0.100
Why?
Mastectomy, Segmental
3
2009
107
0.100
Why?
Follow-Up Studies
6
2019
5428
0.100
Why?
Child Development
1
2019
483
0.100
Why?
Antineoplastic Agents, Hormonal
1
2015
196
0.100
Why?
National Health Programs
1
2014
23
0.100
Why?
Pennsylvania
2
2024
138
0.100
Why?
Patient Satisfaction
2
2013
712
0.100
Why?
Systems Integration
1
2013
36
0.100
Why?
Autism Spectrum Disorder
1
2019
423
0.100
Why?
Infant
3
2020
10090
0.100
Why?
Bridged-Ring Compounds
2
2023
31
0.100
Why?
Health Status Indicators
1
2014
167
0.100
Why?
Computer Simulation
2
2023
1003
0.100
Why?
Cerebrovascular Disorders
1
2014
105
0.100
Why?
Helping Behavior
1
2013
19
0.090
Why?
Kaplan-Meier Estimate
3
2021
971
0.090
Why?
Quality of Health Care
2
2008
693
0.090
Why?
Pilot Projects
3
2021
1897
0.090
Why?
Medical Audit
1
2013
77
0.090
Why?
Occupations
1
2012
51
0.090
Why?
Mandatory Programs
1
2012
16
0.090
Why?
Insurance, Pharmaceutical Services
1
2012
24
0.090
Why?
Pregnancy, Unwanted
1
2012
15
0.090
Why?
Intensive Care Units, Neonatal
1
1996
293
0.090
Why?
Maryland
3
1997
67
0.090
Why?
Life Tables
2
2008
21
0.090
Why?
Prospective Studies
3
2017
8075
0.090
Why?
Cost Control
1
2012
38
0.090
Why?
Cause of Death
1
2014
471
0.090
Why?
Goals
2
2023
185
0.090
Why?
Self Disclosure
1
2011
61
0.090
Why?
Community Health Services
1
2013
231
0.090
Why?
Contraceptive Agents, Female
1
2012
80
0.080
Why?
Contraception Behavior
1
2012
108
0.080
Why?
Educational Status
1
2013
470
0.080
Why?
Retreatment
1
2011
80
0.080
Why?
Sepsis
1
2017
664
0.080
Why?
Mental Disorders
2
1997
1169
0.080
Why?
Video Recording
1
2011
219
0.080
Why?
Economics, Nursing
1
2010
1
0.080
Why?
Interinstitutional Relations
1
2010
56
0.080
Why?
Stress, Physiological
1
2013
443
0.080
Why?
Insulin
1
2001
2516
0.080
Why?
Access to Information
1
2010
48
0.080
Why?
Guideline Adherence
1
2014
587
0.080
Why?
Mastectomy
1
2011
185
0.080
Why?
Pregnancy Complications
1
1996
603
0.080
Why?
Reproducibility of Results
3
2010
3416
0.080
Why?
Consumer Behavior
1
1990
69
0.080
Why?
Sentinel Surveillance
1
2009
46
0.080
Why?
Bone Marrow Transplantation
1
2011
298
0.080
Why?
Standard of Care
1
2010
81
0.080
Why?
Insurance Claim Reporting
1
2009
26
0.070
Why?
Models, Theoretical
1
2013
560
0.070
Why?
Ohio
1
2009
146
0.070
Why?
Occult Blood
1
2009
40
0.070
Why?
Private Sector
1
2009
50
0.070
Why?
Women's Health
2
2012
316
0.070
Why?
Comparative Effectiveness Research
1
2010
169
0.070
Why?
Physical Exertion
1
2010
205
0.070
Why?
Bias
1
2010
197
0.070
Why?
Linear Models
1
2011
849
0.070
Why?
Gastrointestinal Neoplasms
1
2009
73
0.070
Why?
Home Nursing
1
2008
24
0.070
Why?
Reimbursement Mechanisms
1
2009
79
0.070
Why?
Severity of Illness Index
2
2026
2933
0.070
Why?
Sex Characteristics
2
2022
789
0.070
Why?
Psychometrics
1
2013
731
0.070
Why?
Prevalence
2
2020
2874
0.070
Why?
Education, Professional
1
2008
18
0.070
Why?
Data Interpretation, Statistical
1
2010
368
0.070
Why?
Health Care Surveys
1
2010
536
0.070
Why?
Radiotherapy
1
2008
206
0.060
Why?
Pain
2
2010
791
0.060
Why?
Self Care
1
2010
392
0.060
Why?
Chi-Square Distribution
1
2008
528
0.060
Why?
Pulmonary Disease, Chronic Obstructive
1
2014
920
0.060
Why?
Leukemia
1
2008
246
0.060
Why?
Cognition Disorders
1
2010
544
0.060
Why?
Lung Diseases
1
2012
782
0.060
Why?
National Institutes of Health (U.S.)
1
2006
148
0.060
Why?
Charities
1
2005
12
0.060
Why?
Empirical Research
1
2005
21
0.050
Why?
Hospice Care
1
2007
228
0.050
Why?
Diabetes Mellitus, Type 1
1
2001
3937
0.050
Why?
Diagnosis-Related Groups
1
2003
35
0.050
Why?
Randomized Controlled Trials as Topic
1
2010
1751
0.050
Why?
Florida
2
2014
117
0.050
Why?
Resource Allocation
1
2003
52
0.050
Why?
Pandemics
2
2022
1711
0.050
Why?
Health Surveys
2
2007
520
0.050
Why?
Causality
1
2023
127
0.050
Why?
Social Security
1
2002
5
0.050
Why?
Selection Bias
1
2002
38
0.050
Why?
Markov Chains
2
2017
132
0.050
Why?
Motor Activity
1
2007
718
0.050
Why?
Sampling Studies
1
2002
98
0.040
Why?
Mastectomy, Radical
1
2001
4
0.040
Why?
Diagnostic Tests, Routine
1
2002
107
0.040
Why?
Interviews as Topic
1
2005
916
0.040
Why?
Insulin, Long-Acting
1
2001
65
0.040
Why?
Family Characteristics
1
2002
197
0.040
Why?
Insulin Glargine
1
2001
88
0.040
Why?
Arrhythmias, Cardiac
1
2023
356
0.040
Why?
Normal Distribution
1
2000
22
0.040
Why?
Drug Evaluation
1
2000
79
0.040
Why?
Pancreatic Neoplasms
1
2008
928
0.040
Why?
Diffusion of Innovation
1
2001
96
0.040
Why?
Nursing Research
1
2000
49
0.040
Why?
Presenteeism
1
2019
6
0.040
Why?
Clinical Trials as Topic
1
2004
1062
0.040
Why?
Palliative Care
1
2007
1022
0.040
Why?
Etidronic Acid
1
1998
3
0.040
Why?
Alendronate
1
1998
14
0.040
Why?
Federal Government
1
2018
23
0.040
Why?
Osteoporosis, Postmenopausal
1
1998
41
0.030
Why?
Receptors, Estrogen
1
2021
404
0.030
Why?
Informed Consent
1
2000
199
0.030
Why?
Ecosystem
1
2022
478
0.030
Why?
Spinal Fractures
1
1998
76
0.030
Why?
Controlled Before-After Studies
1
2017
15
0.030
Why?
Smoking Prevention
1
1998
166
0.030
Why?
Lymph Node Excision
1
2019
173
0.030
Why?
Estrogen Replacement Therapy
1
1998
143
0.030
Why?
Lymphatic Metastasis
1
2019
336
0.030
Why?
Tennessee
1
2017
57
0.030
Why?
Puberty
1
1998
137
0.030
Why?
Hyperglycemia
1
2001
379
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
1997
39
0.030
Why?
Chemoradiotherapy
1
2018
239
0.030
Why?
Patient Isolation
1
2017
20
0.030
Why?
Biopsy, Needle
1
2017
185
0.030
Why?
Utilization Review
1
1996
39
0.030
Why?
Drug Administration Schedule
1
2018
782
0.030
Why?
Arizona
1
1996
80
0.030
Why?
Bacteriological Techniques
1
2017
66
0.030
Why?
Schools
1
2000
449
0.030
Why?
Anticholesteremic Agents
1
2018
155
0.030
Why?
Patient Dropouts
1
1997
66
0.030
Why?
Epidemiological Monitoring
1
2017
70
0.030
Why?
Catheter-Related Infections
1
2017
96
0.030
Why?
Dyslipidemias
1
2018
184
0.030
Why?
Health Policy
1
2019
400
0.030
Why?
Alzheimer Disease
1
2002
630
0.030
Why?
Hospitals, Community
1
1996
67
0.030
Why?
Obstetric Labor, Premature
1
1996
39
0.030
Why?
Neoplasm Invasiveness
1
2017
508
0.030
Why?
Health Resources
2
2009
130
0.030
Why?
Protoporphyrins
1
1993
16
0.030
Why?
Antihypertensive Agents
1
2018
521
0.030
Why?
Telemedicine
1
2023
966
0.020
Why?
Learning Curve
1
2014
71
0.020
Why?
Acute Disease
1
1996
1036
0.020
Why?
Lead
1
1993
71
0.020
Why?
Immunohistochemistry
1
2017
1723
0.020
Why?
Sensitivity and Specificity
3
2009
2000
0.020
Why?
Calcium
1
1998
1191
0.020
Why?
Community Participation
1
2013
123
0.020
Why?
Opioid-Related Disorders
1
2021
605
0.020
Why?
Societies, Medical
1
2016
900
0.020
Why?
Risk
1
2014
923
0.020
Why?
Gastroenterology
1
2014
191
0.020
Why?
General Surgery
1
2014
206
0.020
Why?
Pregnancy
2
2012
7215
0.020
Why?
Hepatitis B
1
1991
66
0.020
Why?
Work Capacity Evaluation
1
2010
11
0.020
Why?
Cooperative Behavior
1
2013
463
0.020
Why?
Contraception
1
2012
170
0.020
Why?
Prognosis
1
2019
4329
0.020
Why?
Budgets
1
2009
14
0.020
Why?
Sigmoidoscopy
1
2009
14
0.020
Why?
Leadership
1
2013
402
0.020
Why?
Task Performance and Analysis
1
2010
198
0.020
Why?
Prostatectomy
1
2009
94
0.020
Why?
Meta-Analysis as Topic
1
2009
173
0.020
Why?
Ambulatory Care
1
2013
610
0.020
Why?
Age of Onset
1
2009
557
0.020
Why?
Occupational Exposure
1
1991
355
0.020
Why?
Psychology
1
2008
86
0.020
Why?
Demography
1
2008
282
0.020
Why?
Least-Squares Analysis
1
2006
73
0.010
Why?
Lifting
1
2006
4
0.010
Why?
Illinois
1
2006
49
0.010
Why?
Mortality
1
2008
380
0.010
Why?
Body Weight
1
1990
972
0.010
Why?
Telephone
1
2007
177
0.010
Why?
Patient Compliance
1
2009
588
0.010
Why?
Prejudice
1
2006
60
0.010
Why?
Myocardial Revascularization
1
2003
85
0.010
Why?
Burnout, Professional
1
2010
488
0.010
Why?
Statistics, Nonparametric
1
2003
428
0.010
Why?
Vaccination
1
1991
1428
0.010
Why?
Behavior
1
2002
90
0.010
Why?
Episode of Care
1
2001
7
0.010
Why?
Decision Trees
1
2001
78
0.010
Why?
Drug Prescriptions
1
2002
288
0.010
Why?
Cardiac Catheterization
1
2003
559
0.010
Why?
Reoperation
1
2001
637
0.010
Why?
Neuropsychological Tests
1
2002
1137
0.010
Why?
Estrogens
1
1998
367
0.010
Why?
Drug Therapy, Combination
1
1998
1043
0.010
Why?
Estradiol
1
1998
515
0.010
Why?
Lead Poisoning
1
1993
18
0.010
Why?
Reference Values
1
1993
798
0.010
Why?
ROC Curve
1
1993
618
0.010
Why?
Program Evaluation
1
1991
944
0.000
Why?
Bradley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)